**Core Concept**
The question is testing knowledge of familial breast cancer genes, specifically those associated with an increased risk of developing breast cancer. Familial breast cancer genes are responsible for inherited patterns of breast cancer, often presenting at a younger age or in multiple family members.

**Why the Correct Answer is Right**
The correct answer is BRCA2. BRCA1 (Breast Cancer Gene 1) and BRCA2 (Breast Cancer Gene 2) are two well-known genes associated with familial breast cancer. They function as tumor suppressors, repairing DNA damage and preventing cancer development. Mutations in these genes can lead to an increased risk of breast, ovarian, and other cancers. BRCA2 mutations are less common than BRCA1 mutations but still significantly increase cancer risk.

**Why Each Wrong Option is Incorrect**
* **Option A:** BRCA1 is a correct answer, as it is a well-established familial breast cancer gene.
* **Option B:** TP53 is not a familial breast cancer gene, but it is a tumor suppressor gene associated with Li-Fraumeni syndrome, which increases the risk of multiple cancers, including breast cancer.
* **Option C:** PTEN is a tumor suppressor gene associated with Cowden syndrome, which increases the risk of breast, thyroid, and other cancers.
* **Option D:** STK11 is associated with Peutz-Jeghers syndrome, which increases the risk of breast, colon, and other cancers.

**Clinical Pearl / High-Yield Fact**
A key point to remember is that BRCA1 and BRCA2 mutations are associated with an increased risk of breast and ovarian cancer, and genetic testing can identify these mutations. This information can be crucial for cancer risk assessment and prevention strategies.

**Correct Answer: C. PTEN. PTEN is a tumor suppressor gene associated with Cowden syndrome, which increases the risk of breast, thyroid, and other cancers.**